Good response. And just to add:
With their record revenues, they failed to mention they had a loss last quarter because of a drop in revenues. They never addressed it or explained it.
Institutional funding is through dilution. They've authorized 400M+ shares to be added to the outstanding amount and they are already starting to get issued. A partner would have been the way shareholders preferred.
Generic pipeline is not growing. Isradipine is delayed...again, until the fall. What about an update on Epic? That would have been nice to hear during the CC!
Why did NasRAT put off an update on ELI-201??? What, did the company go private overnight? Where is the transparency???
The CC was pathetic. And their futile attempts at any positive PR is amateurish. They need some serious help in that department!
They finally posted the financials for last quarter, and with R&D expenses EXCLUDED, it was a loss for the quarter (pay attention pumpers - total revenue minus cost of revenue was a loss). That explains why we have lost over 20% value since the CC. It also explains why they waited until the last day. No hiding bad numbers.
Looking at NVLX yesterday, it rose over 25% on a good PR after slumping the last few days. Maybe the RAT can talk to their CEO about how to handle public relations. They always seem to release PRs which positively affect the share price. ELTP has a PR problem and it needs to be addressed. Current management is not cutting it and they are actually having a negative affect on share price. And trying to hide bad quarterly numbers isn't working! I stand by my declaration - it's a POS!
I'm officially declaring ELTP a POS!
The RAT can't meet shareholder expectations because he sucks at PR and here the share price goes down...again. Down, down, down!
Nice drop at the end of the day, by the way. MMs know how to play this stock. Constant disappointment! Good job, NasRAT!!!
Not looking very promising. Just give me that squeeze so I can get out of this dead money! Meifud is right, until something big happens, this isn't moving. And the big stuff won't happen until the end of the year. Buy back in then.
I don't see why you have to wait that long. This could be a long term play, but it looks like it has a lot of room to get out and then back in at a lower price. Lots of big fluctuations. It went from the upper .30s to the mid .40s. I should have bailed because I felt uneasy about them waiting to the last day to release. And it turned out they had nothing really to report. They were below expectations and there really wasn't any big announcements. I think that was the major disappointment (no announcements/updates) and the reason for the 15% drop. Nasrat making a couple of quotes like "there's no stopping us" doesn't cut it. It's kind of amateur hour if that is his best response at a CC. It was a nice spike at the end; agreed. If it can continue into the .40s next week, I can sell and come back later when we are closer to the end of the year.
Same old song and dance. Pretty pathetic. Tried to get out but waited too long. One more spike, that's all I need - learned my lesson. This is dead money for a while and I'm tired of watching it go up and down. Absolutely no support from management to help drive it up (even though NasRAT thinks its worth over $2). I don't think they want it to go up right now. When I think about the last two CC's and the content, it's clear they are not interested in the share price increasing, or they are just really bad at the PR game. NasRAT could definitely use some help on that end. Lots of inconsistencies on information coming out and even between the rat and Carter (CFO) during the CC. They had different answers as to when the bonds will be paid off, Isradipine is now delayed until the fall, the rat has no problem with the issuance of 108M shares from Lincoln... We won't be getting any help from management, period. So, it's either languish here in limbo watching it push up into the .40s by the MMs and then back down into the .30s, or put your money somewhere else for a while. Regardless, truly disappointed in NasRAT right now and his lack of commitment to the shareholders.
Wrong. There is selling, lots of it. If it was all buying, I would have been able to unload my shares above .40.
Nobody can!!!!!!! Yes, nobody can!!!!!! Hoorah!!!!!
Stupid. What are you, a cheerleader? There were so many inconsistencies in that CC, it was pathetic. They need to hire someone to run their PR. They are no good at it. Ant the share price is reflecting that.
"This prospectus relates to the offer and sale of up to 108,000,000 shares of common stock, par value $0.001, of Elite Pharmaceuticals, Inc., a Nevada corporation, by Lincoln Park Capital Fund, LLC, or Lincoln Park or the selling shareholder.
The shares of common stock being offered by the selling shareholder have been or may be issued pursuant to the purchase agreement dated April 10, 2014 that we entered into with Lincoln Park."
HAVE BEEN or may be issued. Sounds like they are issuing or are about to. They do plan to dilute. They want the equity for the trials. It will happen.
I did. Why is it stupid? Now the revenue decrease is explained. Transparency can be a good thing.
Q1 will reflect the $5 million settlement, so it will look like an incredible quarter, compared to last quarter and yoy. I expect the numbers we are expecting to see this month to continue the positive momentum of revenue growth and additional generic production. I'm wondering if they are waiting for this report until they have approval to begin production of isradipine in their facility. That would be positive as well. But announcing on Friday is bad timing imo. Wait until Monday if you have to, but usually results are posted on Friday when the news is bad. Let's get some momentum out of these numbers and announce when it can ride for a few days without a weekend break!
Get a nice green day yesterday, give it back today. Getting old. It would have been nice to see some PRs this week going into the earnings. I expected to see a good report, but the way ELTP has been floundering, I'm wondering if we can even move into the .40s with great earnings. I think that will be the deciding factor for me. This is becoming dead money and I didn't like that long line of red days we just went through.